Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -6.22% | +78.50% |
2019 | Argos Therapeutics, Inc. Went Out of Business | CI |
2019 | First Amended Liquidation Plan Approved for Argos Therapeutics, Inc. | CI |
Financials (USD)
Sales 2016 | 945K | Sales 2017 | 1.9M | Capitalization | 13.18M |
---|---|---|---|---|---|
Net income 2016 | -53M | Net income 2017 | -40M | EV / Sales 2016 | 200 x |
Net cash position 2016 | 13.11M | Net Debt 2017 | 4.27M | EV / Sales 2017 | 9.19 x |
P/E ratio 2016 |
-2.96
x | P/E ratio 2017 |
-0.22
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 88.73% |
1st Jan change | Capi. | |
---|---|---|
+78.50% | 567K | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- ARGSQ Stock